| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christi Shaw | Executive Chairperson | 2026-05-27 | 4,194 | $8.59 | $36.03kSell |
| Beth C. Seidenberg | Director | 2025-12-18 | 133,333 | $7.50 | $1,000.00kBuy |
| Westlake Biopartners Opportunity Fund I LP | 10% Owner | 2025-12-18 | 133,333 | $7.50 | $1,000.00kBuy |
| Karen Marie Walker | Chief Technology Officer | 2025-12-15 | 23,998 | $4.83 | $115.91kBuy |
| Karen Marie Walker | Chief Technology Officer | 2025-12-15 | 23,998 | $12.20 | $292.78kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vida Ventures LLC | 7.86% | 4,777,060 | $38.55M | Insider |
| Fred E. Cohen | 7.48% | 4,545,651 | $36.68M | Insider |
| Gordonmd Global Investments LP | 6.98% | 4,244,818 | $34.26M | Institution |
| Gilead Sciences Inc | 6.79% | 4,126,119 | $33.30M | Institution |
| Gilead Sciences Inc | 6.79% | 4,126,119 | $33.30M | Insider |
| Westlake Biopartners Opportunity Fund I LP | 6.23% | 3,787,940 | $30.57M | Insider |
| Northpond Ventures III GP LLC | 5.35% | 3,255,426 | $26.27M | Insider |
| Bain Capital Life Sciences Investors LLC | 5.20% | 3,163,868 | $25.53M | Insider |
| Bain Capital Life Sciences Investors LLC | 5.12% | 3,110,000 | $25.10M | Institution |
| Aigh Capital Management LLC | 3.29% | 2,000,000 | $16.14M | Institution |